Be the first at your institution to publish using the nCounter Human Organ Transplant Panel. This gene expression panel profiles 770 genes across 37 pathways and allows you to identify biomarkers for rejection, uncover the mechanisms of tissue damage, and understand toxicities brought on by immunosuppressive drugs.
Proposals must involve high-plex gene expression profiling for projects in transplant research. Topics of interest include the innate and adaptive immune response, inflammation, tissue damage, and immunosuppression. One awardee will be granted 24 samples of the Human Organ Transplant Panel and nSolver data analysis for each of the three topics:
• Viral infections
• Organ rejection
• Drug development/safety
The awardees can run their samples either through an nCounter® Analysis System provided by their institution or through a service provider. NanoString will provide the reagents and a data analysis service to analyze the NanoString output from the experiment in the form of a report that includes raw data and a detailed analysis with figures and commentary.
Learn more about NanoString technology by clicking on the links below:
NanoString nCounter® Analysis System
NanoString nSolver™ Analysis Software
NanoString nCounter Human Organ Transplant Panel
Grant submissions must be received by 11:59 PM Pacific Time on November 1, 2019. Winners will be announced on or before November 15, 2019.
Apply now through November 1!
Sharing of Grant Submissions and Publication of Results:
All grant submissions are confidential to the individual submitter and will not be published or distributed. Upon project completion, each grant winner agrees to participate in one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and each winner: webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to use anonymized data from the winner's project in application notes or marketing literature.
Applicants must be actively enrolled or employed at a research institution in a capacity in which they perform life science research and have the ability to analyze samples within two months of award notification. Winner(s) of the grant will receive 24 samples worth of the NanoString Human Organ Transplant Panel for use in this program.